1. Home
  2. DDD vs IRWD Comparison

DDD vs IRWD Comparison

Compare DDD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 3D Systems Corporation

DDD

3D Systems Corporation

N/A

Current Price

$1.53

Market Cap

505.1M

Sector

Technology

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.89

Market Cap

578.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DDD
IRWD
Founded
1986
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
505.1M
578.3M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
DDD
IRWD
Price
$1.53
$4.89
Analyst Decision
Hold
Buy
Analyst Count
4
4
Target Price
$3.50
★ $6.18
AVG Volume (30 Days)
★ 3.1M
2.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 109.79
N/A
EPS
N/A
★ 0.91
Revenue
★ $386,902,000.00
$298,276,000.00
Revenue This Year
$1.69
$59.19
Revenue Next Year
$4.34
$4.80
P/E Ratio
★ N/A
$5.33
Revenue Growth
N/A
★ 8.88
52 Week Low
$1.64
$2.95
52 Week High
$4.12
$5.78

Technical Indicators

Market Signals
Indicator
DDD
IRWD
Relative Strength Index (RSI) 22.83 76.30
Support Level N/A $3.90
Resistance Level $3.76 N/A
Average True Range (ATR) 0.17 0.24
MACD -0.10 0.16
Stochastic Oscillator 0.00 93.10

Price Performance

Historical Comparison
DDD
IRWD

About DDD 3D Systems Corporation

3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: